Effect of rosiglitazone versus placebo on cardiovascular performance and myocardial triglyceride.
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2012
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Apr 2012 Actual patient number changed from 111 to 150 as eported by ClinicalTrials.gov.
- 03 Apr 2012 Company added in association field as reported by ClinicalTrials.gov.
- 03 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.